Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
O. Sibila Vidal (Barcelona, Spain), L. Perea (Barcelona, Spain), E. Cantó (Barcelona, Spain), G. Suarez-Cuartin (Barcelona, Spain), A. Rodrigo-Troyano (Barcelona, Spain), L. Terranova (Milan, Italy), M. Oriano (Milan, Italy), J. Giner (barcelona, Spain), S. Vidal (barcelona, Spain), S. Aliberti (Milan, Italy), J. Chalmers (Dundee, United Kingdom). Antimicrobial peptides and airway bacterial colonization in bronchiectasis. 4948

Member's Comments

No comment yet.

Related content which might interest you: Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease Source: Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016 Year: 2017 Differential inflammatory effects of colonising airway bacteria in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 686s Year: 2004 Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens Source: Eur Respir Rev, 28 (152) 190041; 10.1183/16000617.0041-2019 Year: 2019 Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis Source: ERJ Open Res, 4 (2) 00162-2017; 10.1183/23120541.00162-2017 Year: 2018 The difference of airway microbiota between nontuberculous mycobacteria lung disease and bronchiectasis Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Non-tuberculosis mycobacterium related bronchiectasis is associated with oral commensals in the lower airway Source: International Congress 2019 – The microbiome: novel data across respiratory diseases Year: 2019 Antimicrobial peptides in induced sputum of asthmatic patients Source: Eur Respir J 2005; 26: Suppl. 49, 484s Year: 2005 Chronic bronchial infection/colonisation: aetiology and mechanisms Source: Eur Respir Monogr 2013; 60: 34-45 Year: 2013 Lower airway bacterial colonization patterns and species-specific interactions in COPD Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Bacterial bronchial tree colonization in patients with airway stents Source: Eur Respir J 2005; 26: Suppl. 49, 533s Year: 2005 The pulmonary bacterial and fungal microbiota in sarcoidosis patients. Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys Year: 2021 The impact of bacterial colonisation on airway inflammation in stable COPD Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 The effect of erythromycin on the chronic lower airway infection by pseudomonas aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 640s Year: 2004 Evaluation of the airway microbiome in nontuberculous mycobacteria disease Source: Eur Respir J, 52 (4) 1800810; 10.1183/13993003.00810-2018 Year: 2018 Bacterial colonization/infection of the airway stents Source: International Congress 2017 – Bronchoscopy: from stents to practical tips and tricks Year: 2017 What is bacterial colonisation in COPD? Source: Eur Respir Monogr 2015; 69: 161-171 Year: 2015 Airway microbial and polymicrobial load in COPD Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Susceptibility of problem respiratory pathogens to levofloxacin in cystic fibrosis (CF) Source: Eur Respir J 2002; 20: Suppl. 38, 526s Year: 2002 Multidrug resistant bacteria in bronchiectasis exacerbations Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasis Source: Eur Respir J, 56 (4) 2000769; 10.1183/13993003.00769-2020 Year: 2020